Obstructive sleep apnea, a syndrome leading to recurrent intermittent hypoxia (IH), has been
associated previously with hypercholesterolemia, independent of underlying obesity. We …

Obstructive sleep apnea (OSA), a condition tightly linked to obesity, leads to chronic
intermittent hypoxia (CIH) during sleep. There is emerging evidence that OSA is …

Rationale: Obstructive sleep apnea, a condition leading to chronic intermittent hypoxia
(CIH), is associated with hyperlipidemia, atherosclerosis, and a high cardiovascular risk. A …

Obstructive sleep apnea (OSA) is characterized by chronic intermittent hypoxia (CIH) and
associated with dysregulation of lipid metabolisms and atherosclerosis. Causal relationships …

Obstructive sleep apnea (OSA) induces intermittent hypoxia (IH) during sleep and is
associated with elevated triglycerides (TG). We previously demonstrated that mice exposed …

Obstructive sleep apnea (OSA) is recurrent obstruction of the upper airway leading to sleep
fragmentation and intermittent hypoxia (IH) during sleep. There is growing evidence from …

Obstructive sleep apnoea, a syndrome that leads to recurrent intermittent hypoxia, is
associated with insulin resistance in obese individuals, but the mechanisms underlying this …

RATIONALE: Obstructive sleep apnea results in nocturnal intermittent hypoxia (IH) as a main
trigger for cardiovascular morbidity, including atherosclerosis. IH induces hemodynamic …

OBJECTIVE: Obstructive sleep apnea causes intermittent hypoxia (IH) and is associated
with increased cardiovascular mortality. This increased risk may be attributable to more …

Obesity causes insulin resistance (IR) and nonalcoholic fatty liver disease (NAFLD), but the
relative contribution of sleep apnea is debatable. The main aim of this study is to evaluate …